Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases

Trends in Molecular Medicine

Volumn 17, Issue 12, 2011, Pages 714-724

  Hedrich, Christian M ^a   Tsokos, George C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; MICRORNA;

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; CELL FUNCTION; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; HISTONE MODIFICATION; HUMAN; IMMUNOGENICITY; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; CHROMATIN; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HISTONES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICRORNAS; NUCLEOSOMES; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEVERITY OF ILLNESS INDEX;

EID: 84855961987     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2011.07.005     Document Type: Review

References (100)

1. Altshuler D., et al. Genetic mapping in human disease. Science 2008, 322:881-888.
2. Hedrich C.M. Genetic variation and epigenetic patterns in autoimmunity. J. Genet. Syndr. Gene Ther. 2011, 10.4172/2157-7412.10000e2.
3. Hedrich C.M., Bream J.H. Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol. Res. 2010, 47:185-206.
4. Renaudineau Y., Youinou P. Epigenetics and autoimmunity, with special emphasis on methylation. Keio J. Med. 2011, 60:10-16.
5. Crispín J.C., Tsokos G.C. Interleukin-17-producing T cells in lupus. Curr. Opin. Rheumatol. 2010, 22:499-503.
6. Chen J., et al. B cells contribute to ischemia/reperfusion-mediated tissue injury. J. Autoimmun. 2009, 32:195-200.
7. Gualtierotti R., et al. Updating on the pathogenesis of systemic lupus erythematosus. Autoimmun. Rev. 2010, 10:3-7.
8. Meyer O., et al. Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies. Clin. Exp. Immunol. 1985, 62:678-684.
9. Lee-Kirsch M.A., et al. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J. Mol. Med. 2007, 85:531-537.
10. Suggs M.J., et al. HLA DRB*1503 allelic haplotype predominance and associated immunodysregulation in systemic lupus erythematosus. Exp. Mol. Pathol. 2011, 91:548-562.
11. Moser K.L., et al. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun. 2009, 10:373-379.
12. Zouali M. Epigenetics in lupus. Ann. N. Y. Acad. Sci. 2011, 1217:154-165.
13. Liu Y., et al. Decreased DNA methyltransferase levels contribute to abnormal gene expression in "senescent" CD4(+)CD28(-) T cells. Clin. Immunol. 2009, 132:257-265.
14. Lal G., et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J. Immunol. 2009, 182:259-273.
15. Zhao M., et al. Hypomethylation of IL10 and IL13 promoters in CD4+ T cells of patients with systemic lupus erythematosus. J. Biomed. Biotechnol. 2010, 2010:931018.
16. Lu Q., et al. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J. Immunol. 2005, 174:6212-6219.
17. Singer N.G., et al. Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes. Immunology 1996, 88:537-543.
18. Lu Q., et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum. 2002, 46:1282-1291.
19. Lu Q., et al. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J. Immunol. 2007, 179:6352-6358.
20. Kaplan M.J., et al. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J. Immunol. 2004, 172:3652-3661.
21. Brooks W.H., et al. Epigenetics and autoimmunity. J. Autoimmun. 2010, 34:J207-J219.
22. Basu D., et al. Stimulatory and inhibitory killer Ig-like receptor molecules are expressed and functional on lupus T cells. J. Immunol. 2009, 183:3481-3487.
23. Sunahori K., et al. Methylation status of CpG islands flanking a cAMP response element motif on the protein phosphatase 2Ac alpha promoter determines CREB binding and activity. J. Immunol. 2009, 182:1500-1508.
24. Sunahori K., et al. Promoter hypomethylation results in increased expression of protein phosphatase 2A in T cells from patients with systemic lupus erythematosus. J. Immunol. 2011, 186:4508-4517.
25. Garaud S., et al. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J. Immunol. 2009, 182:5623-5632.
26. Chow J., Heard E. X inactivation and the complexities of silencing a sex chromosome. Curr. Opin. Cell Biol. 2009, 21:359-366.
27. Javierre B.M., et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res. 2010, 20:170-179.
28. Nakkuntod J., et al. Hypomethylation of LINE-1 but not Alu in lymphocyte subsets of systemic lupus erythematosus patients. Clin. Chim. Acta 2011, 412:1457-1461.
29. Gorelik G., et al. Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. J. Immunol. 2007, 179:5553-5563.
30. Rai K., et al. DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45. Cell 2008, 135:1201-1212.
31. Li Y., et al. Overexpression of the growth arrest and DNA damage-induced 45alpha gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells. Arthritis Rheum. 2010, 62:1438-1447.
32. Lei W., et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand. J. Rheumatol. 2009, 38:369-374.
33. Januchowski R., et al. Prevalence of ZAP-70, LAT, SLP-76, and DNA methyltransferase 1 expression in CD4+ T cells of patients with systemic lupus erythematosus. Clin. Rheumatol. 2008, 27:21-27.
34. Wang G.S., et al. Ultraviolet B exposure of peripheral blood mononuclear cells of patients with systemic lupus erythematosus inhibits DNA methylation. Lupus 2009, 18:1037-1044.
35. Balada E., et al. Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus. Immunology 2008, 124:339-347.
36. Dieker J., Muller S. Epigenetic histone code and autoimmunity. Clin. Rev. Allergy Immunol. 2010, 39:78-84.
37. Wilson C.B., et al. Epigenetic control of T-helper-cell differentiation. Nat. Rev. Immunol. 2009, 9:91-105.
38. Brenner C., Fuks F. A methylation rendezvous: reader meets writers. Dev. Cell 2007, 12:843-844.
39. Ng H.H., et al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat. Genet. 1999, 23:58-61.
40. Zhang Y., et al. Chromatin methylation activity of Dnmt3a and Dnmt3a/3L is guided by interaction of the ADD domain with the histone H3 tail. Nucleic Acids Res. 2010, 38:4246-4253.
41. Mishra N., et al. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J. Clin. Invest. 2003, 111:539-552.
42. Nambiar M.P., et al. Effect of trichostatin A on human T cells resembles signaling abnormalities in T cells of patients with systemic lupus erythematosus: a new mechanism for TCR zeta chain deficiency and abnormal signaling. J. Cell Biochem. 2002, 85:459-469.
43. Sullivan K.E., et al. The TNFalpha locus is altered in monocytes from patients with systemic lupus erythematosus. Clin. Immunol. 2007, 123:74-81.
44. Crispín J.C., Tsokos G.C. Transcriptional regulation of IL-2 in health and autoimmunity. Autoimmun. Rev. 2009, 8:190-195.
45. Tenbrock K., et al. The transcriptional repressor cAMP response element modulator alpha interacts with histone deacetylase 1 to repress promoter activity. J. Immunol. 2006, 177:6159-6164.
46. Hu N., et al. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice. Scand. J. Rheumatol. 2009, 38:464-471.
47. Nishida K., et al. Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1/Cip1) expression. Arthritis Rheum. 2004, 50:3365-3376.
48. Arbuckle M.R., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 2003, 349:1526-1533.
49. Savill J., et al. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2002, 2:965-975.
50. Herrmann M., et al. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 1998, 41:1241-1250.
51. Karouzakis E., et al. Epigenetic control in rheumatoid arthritis synovial fibroblasts. Nat. Rev. Rheumatol. 2009, 5:266-272.
52. Dieker J.W., et al. Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. Arthritis Rheum. 2007, 56:1921-1933.
53. Godde J.S., Ura K. Cracking the enigmatic linker histone code. J. Biochem. 2008, 143:287-293.
54. Muñoz L.E., et al. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat. Rev. Rheumatol. 2010, 6:280-289.
55. Denli A.M., et al. Processing of primary microRNAs by the microprocessor complex. Nature 2004, 432:231-235.
56. Gregory R.I., et al. The microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235-240.
57. Thai T.H., et al. Is there a link between dysregulated miRNA expression and disease?. Discov. Med. 2010, 10:184-194.
58. Grishok A., et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 2001, 106:23-34.
59. Hutvágner G., et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001, 293:834-838.
60. Mello C.C., Conte D. Revealing the world of RNA interference. Nature 2004, 431:338-342.
61. Pillai R.S., et al. Repression of protein synthesis by miRNAs: how many mechanisms?. Trends Cell Biol. 2007, 17:118-126.
62. Fabian M.R., et al. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 2010, 79:351-379.
63. Chen C.Z., et al. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303:83-86.
64. Lindsay M.A. microRNAs and the immune response. Trends Immunol. 2008, 29:343-351.
65. Xiao C., Rajewsky K. MicroRNA control in the immune system: basic principles. Cell 2009, 136:26-36.
66. Chuang J.C., et al. Epigenetics and microRNAs. Pediatr. Res. 2007, 61:24R-29R.
67. Li Q.J., et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007, 129:147-161.
68. Xiao C., et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007, 131:146-159.
69. Zhou B., et al. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:7080-7085.
70. Tang Y., et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009, 60:1065-1075.
71. Zhao X., et al. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum. 2010, 62:3425-3435.
72. Pan W., et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J. Immunol. 2010, 184:6773-6781.
73. Xiao C., et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 2008, 9:405-414.
74. Fabbri M., et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:15805-15810.
75. Garzon R., et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 2009, 113:6411-6418.
76. Ng E.K., et al. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br. J. Cancer 2009, 101:699-706.
77. Zhao S., et al. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum. 2011, 63:1376-1386.
78. Lashine Y.A., et al. Expression signature of microRNA-181-a reveals its crucial role in the pathogenesis of paediatric systemic lupus erythematosus. Clin. Exp. Rheumatol. 2011, 29:351-357.
79. Han L., et al. DNA methylation regulates microRNA expression. Cancer Biol. Ther. 2007, 6:1284-1288.
80. Scott G.K., et al. Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res. 2006, 66:1277-1281.
81. Neidhart M., et al. Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum. 2000, 43:2634-2647.
82. Neumann E., et al. Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends Mol. Med. 2010, 16:458-468.
83. Dieudé P. Rheumatic diseases: environment and genetics. Joint Bone Spine 2009, 76:602-607.
84. Nile C.J., et al. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum. 2008, 58:2686-2693.
85. Takami N., et al. Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells. Arthritis Rheum. 2006, 54:779-787.
86. Wang Y., et al. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum. 2006, 54:2271-2279.
87. Huber L.C., et al. Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum. 2007, 56:1087-1093.
88. Stanczyk J., et al. Altered expression of miR-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum. 2011, 63:373-381.
89. Stanczyk J., et al. Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008, 58:1001-1009.
90. Alevizos I., et al. MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome. Arthritis Rheum. 2011, 63:535-544.
91. Bulosan M., et al. Inflammatory caspases are critical for enhanced cell death in the target tissue of Sjögren's syndrome before disease onset. Immunol. Cell Biol. 2009, 87:81-90.
92. Tuddenham L., et al. The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett. 2006, 580:4214-4217.
93. Li H., et al. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J. Clin. Invest. 2009, 119:3666-3677.
94. Noonan E.J., et al. miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 2009, 28:1714-1724.
95. Meda F., et al. The epigenetics of autoimmunity. Cell Mol. Immunol. 2011, 8:226-236.
96. Zuvich R.L., et al. Genetics and pathogenesis of multiple sclerosis. Semin. Immunol. 2009, 21:328-333.
97. Chao M.J., et al. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex. Hum. Mol. Genet. 2009, 18:261-266.
98. Mastronardi F.G., et al. Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated. J. Neurosci. Res. 2007, 85:2006-2016.
99. Karouzakis E., et al. DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 2009, 60:3613-3622.
100. Camelo S., et al. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2005, 164:10-21.